New Formula to Predict the Need for Reconstructive Coverage Following Mastectomy

February 17, 2024 updated by: Joseph Rizk Awad, Zagazig University

New Formula to Predict Failure of Primary Closure and the Need for Reconstructive Coverage Following Mastectomy.

Mastectomy is a cornerstone operative procedure in breast cancer treatment leaving a raw area behind with possibility of failure of primary closure sometimes with unavailability of facilities of reconstruction. This opened the door for this research to find a formula to predict the need of reconstruction

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Surgical intervention for breast cancer includes dealing with the primary tumour, added to it is the axillary dissection with variable options in both of them according to multiple factors. Mastectomy represents a part of several operations as radical and modified radical mastectomy, while in others it may be the whole operation as in palliative simple mastectomy. Moreover, re-excision of local recurrence is another form of surgical intervention.

At the step of mastectomy or re-excision of locally recurrent disease, the challenge of closure may arise, as simple primary closure may not be possible because of wide wound gap. In this situation, reconstruction is unavoidably needed and this situation represents one of two situations in which reconstruction is indicated.

As reconstruction sometimes needs certain expertise which may not be available momentarily and needs previous arrangement. Moreover sometimes mastectomy exceeds the previous expectation leaving a big gap beyond simple approximation, so the investigators developed a formula to assess the need of reconstructive coverage.

Study Type

Observational

Enrollment (Actual)

74

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sharqia
      • Zagazig, Sharqia, Egypt, 44519
        • Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

breast care clinic

Description

Inclusion Criteria:

  • Patients diagnosed with breast cancer primary or recurrent, early, locally advanced or metastatic, as long as they were assigned to be treated with any procedure in which mastectomy is part or all of the procedure, were included in this study.

Exclusion Criteria:

  1. Any patient diagnosed with breast cancer and planned to be treated with conservative breast cancer
  2. Any patient whose design for excision was not regular ellipse but an irregularly tailored excision margin
  3. Any patient with ischemic flaps (due to excessive tension or wrong dissection) following mastectomy
  4. Any patient had skin disease affecting its healthiness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
mastectomy group
patients with breast cancer and eligible for mastectomy
mastectomy either simple or modified radical

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clavicle-7th rib/sternal length ratio
Time Frame: for each patient at time of operation
the ratio of clavicle-7th rib in relation to the length of the sternum
for each patient at time of operation
Upper flap length stretch ratio
Time Frame: for each patient at time of operation
the ratio of the perpendicular line from the highest point of the upper border of mastectomy ellipse to the clavicle originally in relation to the length after stretch
for each patient at time of operation
Lower flap length stretch ratio
Time Frame: for each patient at time of operation
the ratio of the perpendicular line from the lowest point of the lower border of mastectomy ellipse to the 7th rib originally to the length after stretch
for each patient at time of operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
flap index
Time Frame: through study completion, an average of 3 years
entangling of the above measurement in an equation to yield a number so when the distance from the clavicle to the 7th rib (in the midclavicular plane) is subtracted from it, a number is yielded, predicting the feasibility of closure without need to reconstruction
through study completion, an average of 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2020

Primary Completion (Actual)

August 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

December 15, 2020

First Submitted That Met QC Criteria

December 18, 2020

First Posted (Actual)

December 21, 2020

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 17, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • mastectomy coverage formula 20

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe